Press Releases

Mural Health and ICON Announce Partnership to Enhance Participant and Site Experience in Clinical Trials

Mural Health Technologies, Inc., a patient-first clinical trial technology company, and ICON plc (NASDAQ: ICLR), a global healthcare intelligence and clinical research organization, today announce a partnership to utilize the participant management and payments platform, Mural Link.

Owkin Launches ATLANTIS: An Extensive Multimodal Patient Data Discovery Program Across 7 Countries in 11 Therapeutic Areas

Owkin, a pioneer in Agentic AI for decoding the complexities of biology, has launched a comprehensive multimodal patient data discovery program to accelerate multimodal data access and advance medical research.

TrialValue Unveils Groundbreaking Human-Augmented Analytics Intelligence Budget Prediction Engine for Clinical Trials

TrialValue, a platform by RHIEOS Ventures Ltd (UK), has launched a groundbreaking human-augmented analytics intelligence budget prediction engine for clinical trials. Originally developed in 2018 using machine learning, curated datasets, and real-world data, this innovation generates full trial budgets with minimal assumptions, offering speed, confidence, and accuracy. The tool provides financial optimization recommendations and empowers stakeholders to make informed decisions. Larry Ajuwon, Director of RHIEOS Ventures, calls it “TrialValue Clinical R&D Financial Benchmarking’s new deal.” TrialValue aims to enhance financial efficiency in clinical development, reducing delays and uncertainties.

eClinical Solutions Details Strong 2024 and Announces New Products Aimed at Reducing Cycle Times for Biopharma

Company prioritizes efficiency through innovation with new embedded AI and automation platform capabilities, including a GenAI-Powered Chatbot and Clean Progress Tracking

Oxford Nanopore expands compatibility with 10x Genomics to unlock deeper insights in single-cell transcriptomics

Oxford Nanopore has expanded its collaboration with 10x Genomics to help improve single-cell transcriptomics research.

Velsera Drives Momentum in 2024 with Key Platform Advancements and Strategic Growth

Celerion Expands UK Phase 1 Clinical Research Operations With New Agreement to Relocate to Queen’s University Belfast’s iREACH Health – Clinical Research Innovation Center

Celerion proudly announces a new agreement to relocate its U.K. Phase 1 clinical research operations to iREACH Health.

CluePoints named as Finalist in 2025 ACDM Awards

CluePoints, provider of leading statistical and AI-driven software solutions, has been shortlisted for “Team Excellence in the Management of Clinical Data” at the 2025 ACDM Awards.

Phastar Secures SCOPE US ‘Best in Show’ Accolade for Clinical Intelligence Platform

Phastar, a global specialist biometrics & data science contract research organization (CRO), won a Best of Show Award at Summit for Clinical Ops Executives (SCOPE) US 2025.

Bioanalytical CRO, Veloxity Labs, Partners with Aplos Analytics to Transform Pharmacokinetic and Toxicokinetic Analysis

Veloxity Labs clients can now pair PK/TK projects with their bioanalysis for lightning-fast, highly accurate results in minutes.

Yourgene Health Launches IONA Care+ Non-invasive Prenatal Testing Service

Qureight and Avalyn Launch Strategic Partnership in Progressive Pulmonary Fibrosis

A clinical trial for people living with the life-threatening lung condition Progressive Pulmonary Fibrosis (PPF) is using deep learning imaging technology to evaluate a new treatment to tackle the condition for the first time.

Inizio accelerates growth with a trio of strategic leadership appointments

Synexa Life Sciences Achieves Highest Level My Green Lab Certification, Reinforcing Commitment to Lab Sustainability

Synexa Life Sciences has achieved the My Green Lab Certification at the highest ‘Green’ level at its Cape Town, South Africa facility.

Glox Therapeutics Awarded Share of £3M Collaborative Discovery Programme Funding from Cystic Fibrosis Antimicrobial Resistance Syndicate

• £500K grant to advance discovery and development of effective precision antibiotics targeting antimicrobial-resistant lung infections in people with cystic fibrosis • Programme delivered by CF AMR Syndicate offers cross-sector collaboration and support to address urgent unmet need

Pharmapack Europe the ‘Heart of Pharma’ Start-ups in Paris

At Pharmapack Europe 2025, six exceptional start-ups have been honoured with the prestigious ‘Heart of Pharma’ awards, recognising their groundbreaking contributions to drug delivery, packaging, and patient care. Selected from a competitive field of 26 innovators, these companies are transforming healthcare with technologies that promise to revolutionize industry standards. The winners include innovations such as sustainable biofuel-powered electronics, patient-friendly nasal sprays, next-generation intradermal drug delivery devices, and breakthrough vial-filling systems. Representing global excellence, recipients hail from the U.S., UK, Ireland, France, and the DACH region. With over 6,000 attendees and 370 exhibitors, Pharmapack remains the must-attend event for pharma innovation. Don’t miss the chance to cover these transformative start-ups and their award-winning technologies.

UK Biocentre Selects the Azenta Life Sciences BioArc Ultra Automated Storage System to Advance Research Excellence

UK Biocentre has selected the BioArc Ultra™ automated storage system to expand their capacity for large-scale biomedical research by an additional 16million samples, supporting vital projects like the UK’s largest health research program, Our Future Health.

Pharmapack Europe Awards 2025 Winners

Pharmapack Europe 2025 proudly announces the winners of its newly reformatted Pharmapack Awards, recognising excellence across six transformative categories in pharmaceutical packaging and drug delivery. This year’s honourees include innovative advancements in sustainable materials, patient-centered design, and next-generation devices—all poised to redefine healthcare delivery. Notable winners include SHL Medical’s Elexy™ reusable electromechanical autoinjector, Huhtamaki’s Omnilock™ Ultra PAPER for eco-friendly packaging, and Mitsubishi Gas Chemical’s OXYCAPT multilayer vial for gene therapy. The prestigious Woman of the Year Award celebrates Asmita Khanolkar of SMC Ltd. for her decades-long contributions to drug-device innovation.

The MAP Group Unites Three Companies Under One New Brand Name, Kintiga

The MAP Group unites three companies under one new brand name, Kintiga

MaxisIT Launches Site Copilot: A Conversational AI Solution to Transform Clinical Trial Site Operations

MaxisIT introduces Site Copilot, an AI-driven conversational agent built on DTect AI, designed to streamline clinical trial site operations. It enhances regulatory compliance, quality management, and patient engagement by integrating seamlessly into existing workflows.